These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 12638115

  • 1. Changes in movement characteristics of the spastic upper extremity after botulinum toxin injection.
    Hurvitz EA, Conti GE, Brown SH.
    Arch Phys Med Rehabil; 2003 Mar; 84(3):444-54. PubMed ID: 12638115
    [Abstract] [Full Text] [Related]

  • 2. Motor control testing of upper limb function after botulinum toxin injection: a case study.
    Hurvitz EA, Conti GE, Flansburg EL, Brown SH.
    Arch Phys Med Rehabil; 2000 Oct; 81(10):1408-15. PubMed ID: 11030508
    [Abstract] [Full Text] [Related]

  • 3. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD, Vuadens P, van Wijck FM, Stark S, Johnson GR, Barnes MP.
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [Abstract] [Full Text] [Related]

  • 4. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.
    Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
    [Abstract] [Full Text] [Related]

  • 5. Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.
    Lee HM, Chen JJ, Wu YN, Wang YL, Huang SC, Piotrkiewicz M.
    Arch Phys Med Rehabil; 2008 Apr; 89(4):692-9. PubMed ID: 18374000
    [Abstract] [Full Text] [Related]

  • 6. Spasticity and Range of Motion Over Time in Stroke Patients Who Received Multiple-Dose Botulinum Toxin Therapy.
    Ro T, Ota T, Saito T, Oikawa O.
    J Stroke Cerebrovasc Dis; 2020 Jan; 29(1):104481. PubMed ID: 31699575
    [Abstract] [Full Text] [Related]

  • 7. Use of three-dimensional kinematic analysis following upper limb botulinum toxin A for children with hemiplegia.
    Mackey AH, Miller F, Walt SE, Waugh MC, Stott NS.
    Eur J Neurol; 2008 Nov; 15(11):1191-8. PubMed ID: 18727674
    [Abstract] [Full Text] [Related]

  • 8. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 Nov; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.
    Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.
    Neurorehabil Neural Repair; 2012 Sep; 26(7):812-21. PubMed ID: 22371239
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of Dual Therapy with Botulinum Toxin A Injection and Electromyography-controlled Functional Electrical Stimulation on Active Function in the Spastic Paretic Hand.
    Tsuchiya M, Morita A, Hara Y.
    J Nippon Med Sch; 2016 Sep; 83(1):15-23. PubMed ID: 26960584
    [Abstract] [Full Text] [Related]

  • 14. Effect of addition of botulinum toxin-A to standardized therapy for dynamic manual skills measured with kinematic aiming tasks in children with spastic hemiplegia.
    Rameckers EA, Duysens J, Speth LA, Vles HJ, Smits-Engelsman BC.
    J Rehabil Med; 2010 Apr; 42(4):332-8. PubMed ID: 20461335
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Apr; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M, Kozlowski O, Froger J.
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [Abstract] [Full Text] [Related]

  • 17. Upper extremity function and occupational performance in children with spastic cerebral palsy following lower extremity botulinum toxin injections.
    Keren-Capelovitch T, Jarus T, Fattal-Valevski A.
    J Child Neurol; 2010 Jun; 25(6):694-700. PubMed ID: 20508235
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.
    Brashear A, McAfee AL, Kuhn ER, Fyffe J.
    Arch Phys Med Rehabil; 2004 May; 85(5):705-9. PubMed ID: 15129392
    [Abstract] [Full Text] [Related]

  • 19. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.